Treating the root cause of the pain. Not the symptoms.

Instead of costly procedures, such as spinal fusion or long-term physiotherapy, our cLBP treatment is an easily performed, single injection procedure that stabilizes the disk by transforming it to connective tissue. Unlike any other currently available treatment this has the potential to permanently remove or reduce the pain significantly faster than surgical intervention.

Healthy disc

An intervertebral disc consists of two main parts: the disc centre and the wall. The disc centre consists largely of a highly hydrated gel together with nucleus pulposus cells and fibroblasts.


When a disc degenerates it becomes less stable and pro-inflammatory substances formed during the degenerative process can leak from the inner core of the disc. Pain-sensing nerves within and outside the wall of the disc are activated. These processes cause back pain.

Treated disc

By injecting a biologically active substance directly into the degenerated intervertebral disc, the cells are triggered to produce collagen and transform the damaged disc into connective tissue. This helps re-stabilize the intervertebral segment and reduces diffusion of pro-inflammatory substances.

Market outlook: 5 million treatable patients only in the US

We are currently taking the next step in our exciting journey towards an injection-based treatment for chronic low back pain. With our STA-363 treatment undergoing clinical phase 1b, we are one step closer to market.

Our market


We are participating in several conferences and industry event every year. Please do not hesitate to contact us to meet up.

Coming events
9 September 2018

Stayble is selected to present at NOME Start-up Competition

Stayble is one of the 9 out of 70 applying companies selected to present at the Nordic mentor network for entrepreneurship (NOME) Start-up Competition. To attend, sign up at

Read more
1 July 2018

Meet Stayble at Park Annual in Gothenburg

Meet Stayble at Park annual on the 27th of September.

Read more

Latest news

Stay updated on our development journey

5 October 2018

Björns Strömqvist and Jan Kallewaard are appointed Scientific Advisors

Stayble has appointed Björn Strömqvist and Jan Kallewaard as Scientific Advisors. Both have extensive knowledge within the field of back pain both from a scientific and clinical perspective. The advisors…

Read more
25 August 2018

Patient recruitment finalised in Stayble´s clinical phase Ib trial

Stayble is happy to announce that the last patient in the ongoing clinical phase Ib trial was treated with STA363 on August 25. Preliminary results will be available before the…

Read more

Get in touch

We are always looking for passionate people who are interested in joining us to help realizing our vision. Please leave your contact details and we will get back to you shortly.